1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan G‑A, Dilaveris PE, Fauchier L, Filippatos G et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 42(5):373–498
2. Kuck K‑H, Merkely B, Zahn R, Arentz T, Seidl K, Schlüter M, Tilz RR, Piorkowski C, Gellér L, Kleemann T, Hindricks G (2019) Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial. Circ Arrhythm Electrophysiol 12:e7731
3. Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, Sugumar H, Lockwood SM, Stokes MB, Pathik B, Nalliah CJ, Wong GR et al (2017) Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol 70:1949–1961
4. Arbelo E, Brugada J, Blomström-Lundqvist C, Laroche C, Kautzner J, Pokushalov E, Raatikainen P, Efremidis M, Hindricks G, Barrera A, Maggioni A, Tavazzi L et al (2017) Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1‑year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J 38:1303–1316
5. Takarada K, Overeinder I, de Asmundis C, Stroker E, Mugnai G, de Regibus V, Moran D, Coutino-Moreno H, Abugattas J‑P, Choudhury R, Ruggiero D, Paparella G et al (2017) Long-term outcome after second-generation cryoballoon ablation for paroxysmal atrial fibrillation—a 3-years follow-up. J Interv Card Electrophysiol 49:93–100